Perrigo Posts Stable Third Quarter While Addressing Branded Consumer and Prescription Segment Issues
We don’t anticipate a change to our fair value estimate for Perrigo as third-quarter results were mostly in line with our expectations. The company continues to face significant challenges in both its branded consumer health and prescription topicals segments, which have driven the firm’s recent underperformance. Management also plans to evaluate alternatives for its Tysabri and prescription topicals segments by the end of the first quarter in 2017. We place a high probability on the sale of its...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.